Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Image Recovery Should Begin With Company Efforts – Merck Exec

Executive Summary

Improving the pharmaceutical industry's image should begin with individual company efforts, according to a Merck communications exec

You may also be interested in...



Industry’s Reputation On The Way Up, No Thanks To The Media, Garnier Says

The reputation of the pharma industry is improving, in part driven by the success of Medicare Part D, according to GSK CEO J.P. Garnier

Industry’s Reputation On The Way Up, No Thanks To The Media, Garnier Says

The reputation of the pharma industry is improving, in part driven by the success of Medicare Part D, according to GSK CEO J.P. Garnier

Consumers’ Mistaken Beliefs About Rx Costs Fuel Mistrust Of Industry – PWC

The public perception that drug costs take a higher share of total medical expenses than they actually do contributes to consumers' mistrust of the pharmaceutical industry, a PriceWaterhouseCoopers survey suggests

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047225

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel